Neuren Pharmaceuticals Limited (ASX: NEU)

Neuren Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	17.09	40.18	36.78	24.19	13.84
Short-Term Investments	211.45	0	0	0	0
Cash & Cash Equivalents	228.54	40.18	36.78	24.19	13.84
Cash Growth	468.79%	9.24%	52.07%	74.72%	-41.28%
Receivables	14.41	1.09	1.42	0.76	0.55
Inventory	0	0	0	-0.76	-0.54
Other Current Assets	4.21	1.98	1.84	0.76	0.54
Total Current Assets	247.16	43.25	40.04	24.94	14.4
Property, Plant & Equipment	0.04	0.02	0.01	0.01	0.01
Other Long-Term Assets	0.77	0	0	-0	-0
Total Long-Term Assets	0.81	0.02	0.01	0.01	0.01
Total Assets	247.97	43.27	40.06	24.95	14.41
Accounts Payable	0.68	0.26	0.25	0.17	0.34
Other Current Liabilities	42.09	1.42	0.56	0.59	0.22
Total Current Liabilities	42.76	1.68	0.8	0.75	0.56
Total Liabilities	42.76	1.68	0.8	0.75	0.56
Common Stock	173.13	167.74	167.58	145.57	126.43
Retained Earnings	38.39	-118.69	-118.88	-111.08	-104.08
Comprehensive Income	-6.31	-7.46	-9.45	-10.28	-8.5
Shareholders' Equity	205.21	41.59	39.25	24.2	13.85
Total Liabilities and Equity	247.97	43.27	40.06	24.95	14.41
Net Cash / Debt	228.54	40.18	36.78	24.19	13.84
Net Cash / Debt Growth	468.79%	9.24%	52.07%	74.72%	-46.13%
Net Cash Per Share	1.75	0.31	0.31	0.23	0.14
Working Capital	204.39	41.57	39.24	24.19	13.84
Book Value Per Share	1.61	0.33	0.33	0.23	0.14

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.